News

Latest

by John Supplitt
When hundreds of leaders gather virtually February 17–18 for the AHA Rural Health Care Leadership Conference, there will be opportunities for you to make, build and renew connections that help innovate and transform health care, through a pioneering approach toward conferencing.
In this AHA Hospitals Against Violence Q&A blog, AHA General Counsel Mindy Hatton interviews Curt Kirschner, partner and a leader of Jones Day’s Anti-Human Trafficking Task Force, to discuss the partnership working to expand hospitals’ leadership roles in the fight against human trafficking.
The Department of Health and Human Services and the Office of the Surgeon General released a federal call-to-action for efforts to reduce suicide rates, improve resilience and broaden the perceptions of suicide.
The Centers for Medicare & Medicaid Services released its request for applications for the Geographic Direct Contracting Model, known as Geo.
The Centers for Medicare & Medicaid Services released a request for applications to participate in the Part D Payment Modernization Model in calendar year 2022.
Only 132 of the 334 off-campus provider-based hospital outpatient departments that requested a “mid-build” exception for Medicare to continue to pay them under the outpatient prospective payment system qualified for the exception, the Centers for Medicare & Medicaid Services announced.
U.S. hospitals and other non-profit and for-profit entities with experience using telehealth technologies to serve rural underserved populations can apply through April 2 for up to $350,000 each to implement and evaluate direct-to-consumer telehealth technologies to increase access to health care services, the Health Resources and Services Administration announced.
The AHA published its 2021 Strategic Plan outlining the association’s operating blueprint for the year.
The Food and Drug Administration updated its guidance and webpage on COVID-19 convalescent plasma.
The American Medical Association announced Current Procedural Terminology codes for reporting the single-dose Janssen (Johnson & Johnson) COVID-19 vaccine and its administration on medical claims if the Food and Drug Administration approves the candidate vaccine or authorizes it for emergency use.